TRCT
PIII icon

Tower Research Capital (TRC)’s P3 Health Partners PIII Stock Holding History

Tower Research Capital (TRC)’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-254
Closed -$4.91K – 5927
2024
Q3 		$4.91K Sell
254
-236
-48% -$6.18K ﹤0.01% 4376
2024
Q2 		$11K Buy
490
+285
+139% +$8.51K ﹤0.01% 4106
2024
Q1 		$10.6K Buy
205
+45
+28% +$2.5K ﹤0.01% 3685
2023
Q4 		$11.3K Sell
160
-705
-82% -$48.6K ﹤0.01% 4145
2023
Q3 		$63.6K Buy
865
+682
+373% +$70.8K ﹤0.01% 2346
2023
Q2 		$27.4K Sell
183
-40
-18% -$5.53K ﹤0.01% 3110
2023
Q1 		$12K Buy
223
+136
+156% +$8.17K ﹤0.01% 4113
2022
Q4 		$8K Buy
87
+40
+85% +$8.66K ﹤0.01% 4439
2022
Q3 		$11K Sell
47
-9
-16% -$2.25K ﹤0.01% 4456
2022
Q2 		$10K Buy
56
+54
+2,700% +$15K ﹤0.01% 4473
2022
Q1 		$1K Sell
2
-116
-98% -$34.8K ﹤0.01% 5837
2021
Q4 		$42K Buy
118
+83
+237% +$39.6K ﹤0.01% 2903
2021
Q3 		$17K Buy
35
+33
+1,650% +$16.3K ﹤0.01% 3875
2021
Q2 		$1K Buy
+2
New +$981 ﹤0.01% 5238

Other funds holding PIII

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIA
Wealthedge Investment Advisors New York $294M AUM 20.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return

Tower Research Capital (TRC)'s PIII Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of P3 Health Partners (PIII) in Q4 2024, closing a stake of 254 shares — an estimated $4.91K sold.

Tower Research Capital (TRC) first reported a position in PIII in Q2 2021 and held it in 14 quarters. The position peaked at $63.6K in Q3 2023. 37 funds tracked by Wall St. Rank hold PIII as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining P3 Health Partners position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 254 P3 Health Partners shares in Q4 2024, an estimated $4.91K.
  • Tower Research Capital (TRC) first reported a position in P3 Health Partners in Q2 2021 and held it in 14 quarters.
  • Tower Research Capital (TRC)'s P3 Health Partners position peaked at $63.6K in Q3 2023.
  • 37 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.